Co-Diagnostics, Inc. Common Stock (CODX) is a publicly traded Healthcare sector company. As of September 14, 2026, CODX trades at $1.12 with a market cap of $7.82M and a P/E ratio of -0.03. CODX moved +2.73% today. Year to date, CODX is -79.34%; over the trailing twelve months it is -89.15%. Its 52-week range spans $0.94 to $46.50. Analyst consensus is moderatebuy with an average price target of $4.00. Rallies surfaces CODX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Co-Diagnostics, Inc. Common Stock (CODX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CODX moved +2.73% today. Analyst consensus is moderatebuy.
| Metric | Value |
|---|---|
| Price | $1.12 |
| Market Cap | $7.82M |
| P/E Ratio | -0.03 |
| EPS | $-39.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.50 |
| 52-Week Low | $0.94 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $721.39K |
| Net Income | $-47.06M |
| Gross Margin | 43.48% |
1 analysts cover CODX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $4.00.